Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Eisner

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|February 19, 2011
Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smokingMaciej Lukasz Goniewicz, Mark D Eisner, Eduardo Lazcano-Ponce, et al.
Respiratory Research|January 31, 2007
Body composition and functional limitation in COPDMark D Eisner, Paul D Blanc, Steve Sidney, et al.
The Journal of Allergy and Clinical Immunology|January 21, 2009
Exposure to traffic: lung function and health status in adults with asthmaJohn R Balmes, Gillian Earnest, Patricia P Katz, et al.
Critical Care Medicine|April 23, 2009
A simple clinical predictive index for objective estimates of mortality in acute lung injuryColin R Cooke, Chirag V Shah, Robert Gallop, et al.
American Journal of Epidemiology|March 18, 2008
Pulmonary function and the risk of functional limitation in chronic obstructive pulmonary diseaseMark D Eisner, Carlos Iribarren, Edward H Yelin, et al.
Medical Care|May 25, 2013
Risk adjustment for health care financing in chronic disease: what are we missing by failing to account for disease severity?Theodore A Omachi, Steven E Gregorich, Mark D Eisner, et al.
The American Journal of Medicine|August 30, 2008
COPD as a systemic disease: impact on physical functional limitationsMark D Eisner, Paul D Blanc, Edward H Yelin, et al.
Annals of Internal Medicine|May 4, 2011
Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trialNicola A Hanania, Oral Alpan, Daniel L Hamilos, et al.
Critical Care Medicine|October 12, 2010
Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patientsS Jean Hsieh, Lorraine B Ware, Mark D Eisner, et al.
Critical Care Medicine|February 27, 2009
Plasma granulocyte colony-stimulating factor levels correlate with clinical outcomes in patients with acute lung injuryBenjamin T Suratt, Mark D Eisner, Carolyn S Calfee, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|February 19, 2011
Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smokingMaciej Lukasz Goniewicz, Mark D Eisner, Eduardo Lazcano-Ponce, et al.
Respiratory Research|January 31, 2007
Body composition and functional limitation in COPDMark D Eisner, Paul D Blanc, Steve Sidney, et al.
The Journal of Allergy and Clinical Immunology|January 21, 2009
Exposure to traffic: lung function and health status in adults with asthmaJohn R Balmes, Gillian Earnest, Patricia P Katz, et al.
Critical Care Medicine|April 23, 2009
A simple clinical predictive index for objective estimates of mortality in acute lung injuryColin R Cooke, Chirag V Shah, Robert Gallop, et al.
American Journal of Epidemiology|March 18, 2008
Pulmonary function and the risk of functional limitation in chronic obstructive pulmonary diseaseMark D Eisner, Carlos Iribarren, Edward H Yelin, et al.
Medical Care|May 25, 2013
Risk adjustment for health care financing in chronic disease: what are we missing by failing to account for disease severity?Theodore A Omachi, Steven E Gregorich, Mark D Eisner, et al.
The American Journal of Medicine|August 30, 2008
COPD as a systemic disease: impact on physical functional limitationsMark D Eisner, Paul D Blanc, Edward H Yelin, et al.
Annals of Internal Medicine|May 4, 2011
Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trialNicola A Hanania, Oral Alpan, Daniel L Hamilos, et al.
Critical Care Medicine|October 12, 2010
Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patientsS Jean Hsieh, Lorraine B Ware, Mark D Eisner, et al.
Critical Care Medicine|February 27, 2009
Plasma granulocyte colony-stimulating factor levels correlate with clinical outcomes in patients with acute lung injuryBenjamin T Suratt, Mark D Eisner, Carolyn S Calfee, et al.
Pageof 12